[
  {
    "ts": "2026-02-11T09:56:00+00:00",
    "headline": "The Zacks Analyst Blog Highlights NVIDIA, Amazon.com, Regeneron, National Presto and AXIL",
    "summary": "NVDA, AMZN and REGN headline Zacks' top stock reports, spotlighting AI growth, cloud momentum and oncology pipeline strength.",
    "url": "https://finance.yahoo.com/news/zacks-analyst-blog-highlights-nvidia-095600402.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "cfb7e045-c1a0-31e0-b7f1-85a706c3a540",
      "content": {
        "id": "cfb7e045-c1a0-31e0-b7f1-85a706c3a540",
        "contentType": "STORY",
        "title": "The Zacks Analyst Blog Highlights NVIDIA, Amazon.com, Regeneron, National Presto and AXIL",
        "description": "",
        "summary": "NVDA, AMZN and REGN headline Zacks' top stock reports, spotlighting AI growth, cloud momentum and oncology pipeline strength.",
        "pubDate": "2026-02-11T09:56:00Z",
        "displayTime": "2026-02-11T09:56:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/ae16b860501e504815b944ed35f1e848",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/kTXlKhlXEFflu4SisSmp.g--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/ae16b860501e504815b944ed35f1e848.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/H0kkyjUl52vGlgfEtNN4Gw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/ae16b860501e504815b944ed35f1e848.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/zacks-analyst-blog-highlights-nvidia-095600402.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/zacks-analyst-blog-highlights-nvidia-095600402.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "AMZN"
            },
            {
              "symbol": "REGN"
            },
            {
              "symbol": "AXIL"
            },
            {
              "symbol": "NPK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-11T09:33:00+00:00",
    "headline": "Evommune rockets on eczema data; AstraZeneca advances GLP-1 pill",
    "summary": "Shares of Evommune nearly doubled on data suggesting it has a potential threat to Dupixent. Elsewhere, a closely watched narcolepsy drug got an FDA decision date and investors scrutinized Upstream’s asthma results.",
    "url": "https://www.biopharmadive.com/news/evommune-eczema-astrazeneca-obesity-upstream-takeda-oveporexton-moderna/811791/",
    "source": "BioPharma Dive",
    "provider": "yfinance",
    "raw": {
      "id": "2d79906b-266e-33bb-9f2c-a672985d2183",
      "content": {
        "id": "2d79906b-266e-33bb-9f2c-a672985d2183",
        "contentType": "STORY",
        "title": "Evommune rockets on eczema data; AstraZeneca advances GLP-1 pill",
        "description": "",
        "summary": "Shares of Evommune nearly doubled on data suggesting it has a potential threat to Dupixent. Elsewhere, a closely watched narcolepsy drug got an FDA decision date and investors scrutinized Upstream’s asthma results.",
        "pubDate": "2026-02-11T09:33:00Z",
        "displayTime": "2026-02-11T09:33:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/biopharma_dive_768/e36d70a3849ea73409df7aca9613c259",
          "originalWidth": 1600,
          "originalHeight": 900,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YSECyFvzK8sIEiUW4LIicA--~B/aD05MDA7dz0xNjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/biopharma_dive_768/e36d70a3849ea73409df7aca9613c259.cf.webp",
              "width": 1600,
              "height": 900,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/heEgXBvKL8Y58FXAXGaXPg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/biopharma_dive_768/e36d70a3849ea73409df7aca9613c259.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "BioPharma Dive",
          "url": "https://biopharmadive.com/"
        },
        "canonicalUrl": {
          "url": "https://www.biopharmadive.com/news/evommune-eczema-astrazeneca-obesity-upstream-takeda-oveporexton-moderna/811791/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/evommune-rockets-eczema-data-astrazeneca-093300749.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "EVMN"
            },
            {
              "symbol": "AZN"
            },
            {
              "symbol": "TAK"
            },
            {
              "symbol": "UPB"
            },
            {
              "symbol": "MRNA"
            },
            {
              "symbol": "REGN"
            },
            {
              "symbol": "397030.KQ"
            },
            {
              "symbol": "SNY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-11T21:05:00+00:00",
    "headline": "Regeneron Announces Investor Conference Presentations",
    "summary": "TARRYTOWN, N.Y., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management participation as follows: TD Cowen 46th Annual Health Care Conference at 9:10 a.m. ET on Wednesday, March 4, 2026Leerink Partners 2026 Global Healthcare Conference at 10:40 a.m. ET on Wednesday, March 11, 2026 The sessions may be accessed from the \"Investors & Media\" page of Regeneron's website at https://investor.regeneron.com/events-and-presentations. Replays and transcript",
    "url": "https://finance.yahoo.com/news/regeneron-announces-investor-conference-presentations-210500206.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "910b8d36-dd8b-3667-bbdf-d19c19b9dd57",
      "content": {
        "id": "910b8d36-dd8b-3667-bbdf-d19c19b9dd57",
        "contentType": "STORY",
        "title": "Regeneron Announces Investor Conference Presentations",
        "description": "",
        "summary": "TARRYTOWN, N.Y., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management participation as follows: TD Cowen 46th Annual Health Care Conference at 9:10 a.m. ET on Wednesday, March 4, 2026Leerink Partners 2026 Global Healthcare Conference at 10:40 a.m. ET on Wednesday, March 11, 2026 The sessions may be accessed from the \"Investors & Media\" page of Regeneron's website at https://investor.regeneron.com/events-and-presentations. Replays and transcript",
        "pubDate": "2026-02-11T21:05:00Z",
        "displayTime": "2026-02-11T21:05:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/2788fcd6c9b4dcf523fc2cc341eb4142",
          "originalWidth": 800,
          "originalHeight": 126,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ohIVokMiKClSVTQVwyB2lw--~B/aD0xMjY7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/2788fcd6c9b4dcf523fc2cc341eb4142.cf.webp",
              "width": 800,
              "height": 126,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YuYzNeQcIK6rRYN1HdT6UA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/2788fcd6c9b4dcf523fc2cc341eb4142.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/regeneron-announces-investor-conference-presentations-210500206.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/regeneron-announces-investor-conference-presentations-210500206.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "REGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]